T1	Species 46 50	mice
T2	Sex 201 205	male
T3	Species 206 210	mice
T4	Species 239 243	mice
T5	Species 294 298	mice
T6	Species 391 395	mice
T7	GroupName 676 689	control group
T8	GroupName 694 712	three noise groups
T9	Dose 783 785	95
T10	TestArticle 764 779	broadband noise
T11	DoseUnits 786 823	decibel sound pressure level (dB SPL)
T15	GroupName 893 903	N20D group
T16	DoseDuration 906 908	10
T17	DoseDurationUnits 909 913	days
T18	DoseFrequency 828 840	4 hr per day
T12	GroupName 915 925	N10D group
T13	GroupName 938 947	N1D group
T19	DoseDurationUnits 933 936	day
T20	DoseDuration 931 932	1
T27	Species 1208 1212	mice
T28	GroupName 1220 1233	control group
T29	GroupName 1745 1762	the control group
T30	GroupName 1767 1785	three noise groups
T32	DoseDuration 1846 1848	10
T33	DoseDurationUnits 1860 1864	days
T31	DoseDuration 1826 1828	20
T34	DoseDurationUnits 1840 1844	days
T35	DoseDuration 1869 1870	1
T36	DoseDurationUnits 1871 1874	day
T37	GroupName 1894 1898	N20D
T38	GroupName 1900 1904	N10D
T39	GroupName 1910 1913	N1D
T40	GroupName 2094 2107	control group
T41	GroupName 2147 2151	N10D
T42	GroupName 2156 2159	N1D
T46	Endpoint 2365 2383	glucose metabolism
T50	Endpoint 2628 2648	β-cell proliferation
T51	Species 2654 2658	mice
T52	Species 2892 2896	mice
T53	GroupName 2822 2825	N1D
T54	TimeEndpointAssessed 2514 2515	1
T55	TimeUnits 2516 2519	day
T43	TimeEndpointAssessed 2521 2522	1
T56	TimeUnits 2523 2527	week
T44	TimeEndpointAssessed 2533 2534	1
T57	TimeUnits 2535 2540	month
T45	Dose 2986 2988	95
T58	DoseDurationUnits 2989 2995	dB SPL
T59	DoseFrequency 3000 3012	4 hr per day
T60	Endpoint 3105 3113	diabetes
T61	DoseDuration 2112 2114	20
T62	DoseDurationUnits 2115 2119	days
T63	Endpoint 3955 3988	Auditory Brainstem Response (ABR)
T66	Endpoint 4322 4325	ABR
T67	Endpoint 4493 4510	glucose tolerance
T68	Species 4573 4577	mice
T69	Endpoint 4721 4740	blood glucose level
T70	Endpoint 4848 4867	serum insulin level
T71	Endpoint 5006 5019;5038 5044	blood glucose levels
T72	Endpoint 5024 5044	serum insulin levels
T73	Endpoint 5210 5223;5280 5317	blood glucose in response to glucose administration
T74	Endpoint 5247 5260;5280 5317	serum insulin in response to glucose administration
T75	Endpoint 5402 5415;5434 5440	blood glucose levels
T76	Endpoint 5420 5440	serum insulin levels
T77	Endpoint 5611 5629	insulin resistance
T78	GroupName 5829 5838	N1D group
T79	GroupName 5847 5854	control
T80	Endpoint 5858 5875	glucose tolerance
T81	Endpoint 5880 5896	insulin response
T83	GroupName 5951 5960	N1D group
T85	Endpoint 5910 5926	insulin response
T86	Endpoint 4446 4463	Glucose Tolerance
T87	Endpoint 5987 6004	Insulin Tolerance
T88	Species 6012 6016	Mice
T92	TimeEndpointAssessed 6194 6196;6226 6249	15 after insulin injection
T93	TimeEndpointAssessed 6198 6200;6226 6249	30 after insulin injection
T94	TimeEndpointAssessed 6202 6204;6226 6249	45 after insulin injection
T95	TimeEndpointAssessed 6206 6208;6226 6249	60 after insulin injection
T96	TimeEndpointAssessed 6210 6212;6226 6249	90 after insulin injection
T97	TimeEndpointAssessed 6218 6221;6226 6249	120 after insulin injection
T99	Species 7155 7159	mice
T100	Endpoint 7664 7684	β-cell proliferation
T102	Endpoint 6621 6629;6645 6652	pancreas weighed
T103	Endpoint 6621 6629;6668 6688	pancreas immunohistochemistry
T104	Endpoint 6892 6906;7051 7071	soleus muscles immunohistochemistry
T105	Endpoint 7122 7142;7401 7411	β-cell proliferation pancreases
T106	GroupName 7485 7494	N1D group
T108	Endpoint 9083 9108;9116 9126	morphological examination pancreases
T109	Endpoint 9237 9248	β-cell mass
T110	EndpointUnitOfMeasure 9250 9273	milligrams per pancreas
T111	Endpoint 9458 9469	β-cell size
T113	Endpoint 9781 9801	β-cell proliferation
T116	Endpoint 10042 10047;10068 10097;10105 10118	level glucose transporter 4 (GLUT4) soleus muscle
T117	Endpoint 10052 10097;10105 10118	distribution of glucose transporter 4 (GLUT4) soleus muscle
T121	Endpoint 11776 11797	Corticosterone Levels
T122	EndpointUnitOfMeasure 12012 12041	nanograms/milliliter of serum
T123	Endpoint 12323 12334	β-cell size
T124	Endpoint 12340 12390	relative insulin fluorescence intensity in β cells
T125	Endpoint 12679 12686;12698 12711	insulin concentration
T126	Endpoint 12690 12711	glucose concentration
T127	GroupName 12942 12953	noise group
T128	GroupName 12962 12975	control group
T129	SampleSize 235 238	288
T130	Endpoint 2295 2312	insulin tolerance
T131	Endpoint 2266 2283	glucose tolerance
T133	TimeEndpointAssessed 4650 4684	after an i.p. injection of glucose
T135	TimeEndpointAssessed 4623 4624;4650 4684	5 after an i.p. injection of glucose
T136	TimeEndpointAssessed 4626 4628;4650 4684	10 after an i.p. injection of glucose
T137	TimeEndpointAssessed 4630 4632;4650 4684	30 after an i.p. injection of glucose
T138	TimeEndpointAssessed 4634 4636;4650 4684	60 after an i.p. injection of glucose
T139	TimeEndpointAssessed 4642 4645;4650 4684	120 after an i.p. injection of glucose
T140	TimeUnits 4646 4649	min
T141	Endpoint 5093 5110;5136 5156	glucose tolerance to glucose challenge
T142	Endpoint 5119 5135;5136 5156	insulin response to glucose challenge
T143	Endpoint 5504 5537	fasting blood glucose level (FBG)
T144	Endpoint 5542 5575	fasting serum insulin level (FSI)
T145	GroupName 7614 7623	N1D group
T147	Strain 42 45	ICR
T148	GroupName 733 745	noise groups
T14	DoseDuration 884 886	20
T149	DoseDurationUnits 887 891	days
T150	GroupName 988 1000	noise groups
T151	TimeEndpointAssessed 1135 1165	after the final noise exposure
T21	TimeEndpointAssessed 1108 1109	1
T152	TimeUnits 1110 1113	day
T22	TimeEndpointAssessed 1115 1116	1
T153	TimeUnits 1117 1121	week
T23	TimeEndpointAssessed 1127 1128	1
T154	TimeUnits 1129 1134	month
T155	GroupName 1318 1338	age-matched controls
T156	TestArticle 1878 1883	noise
T157	DoseDuration 1970 1972	20
T158	DoseDurationUnits 1973 1976	day
T159	GroupName 1985 1989	Sham
T160	DoseDuration 2042 2044	20
T161	DoseDurationUnits 2045 2048	day
T162	TestArticle 2188 2193	noise
T163	TestArticle 2347 2352	noise
T164	TestArticle 2557 2562	noise
T166	TestArticle 2938 2943	Noise
T167	TestArticle 2968 2973	noise
T168	TestArticle 3077 3082	noise
T169	TestArticle 3340 3345	noise
T170	TestArticle 3452 3477	Electrical Gaussian noise
T171	TestArticle 3436 3441	noise
T172	Dose 3687 3698;3703 3709	between 0.1 and 20
T173	DoseUnits 3699 3702	kHz
T174	DoseUnits 3710 3713	kHz
T132	TestArticleVerification 3719 3760;3761 3811	noise level was monitored using a 1/4-in. (6.35 mm) microphone linked to a sound level meter
T175	GroupName 3884 3888	sham
T176	TestArticle 3929 3934	noise
T177	Endpoint 3990 4007	Auditory function
T65	Endpoint 4034 4048	ABR thresholds
T178	TimeEndpointAssessed 4612 4613;4650 4684	0 after an i.p. injection of glucose
T134	TimeUnits 4614 4617	min
T179	TimeEndpointAssessed 5465 5466	0
T180	TimeUnits 5467 5470	min
T181	EndpointUnitOfMeasure 5659 5723	FBG (in millimoles/liter) × FSI (in microunits/milliliter)]/22.5
T89	Endpoint 6131 6159	blood glucose concentrations
T90	Endpoint 6757 6770;7051 7071	soleus muscle immunohistochemistry
T98	Species 6772 6776	mice
T183	TestArticle 7738 7743	noise
T185	TestArticle 7922 7927	noise
T186	TestArticle 7985 7990	noise
T187	TestArticle 7655 7660	noise
T188	Endpoint 7831 7841;7881 7888;7898 7910	pancreases β cells proliferated
T189	Endpoint 8120 8140;8145 8167;8197 8205	Immunohistochemistry Morphological Analysis pancreas
T190	Endpoint 8120 8140;8145 8167;8210 8224	Immunohistochemistry Morphological Analysis soleus muscles
T112	Endpoint 9619 9658	relative insulin content in the β cells
T115	Endpoint 10215 10257	relative GLUT4 content in the muscle cells
T120	Endpoint 11803 11829	serum corticosterone level
T196	TestArticle 12824 12829	noise
T197	TestArticle 13038 13043	noise
T198	TestArticle 12634 12639	noise
T199	Endpoint 12400 12436	percentages of proliferating β cells
T200	TestArticle 1151 1156	noise
T201	TimeEndpointAssessed 2902 2935	sacrificed at the end time points
T182	EndpointUnitOfMeasure 9681 9739	average intensity of insulin immunofluorescence per β cell
T114	EndpointUnitOfMeasure 9922 9997	ratio of insulin/BrdU double-positive cells to total insulin-positive cells
T184	EndpointUnitOfMeasure 9501 9551	total area of the β cells by the number of β cells
T119	Endpoint 10423 10436;10661 10683	Soleus muscle protein concentrations
T26	TimeEndpointAssessed 1183 1184	1
T194	TimeUnits 1184 1187	MPN
T24	TimeEndpointAssessed 1167 1168	1
T195	TimeUnits 1168 1171	DPN
T25	TimeEndpointAssessed 1173 1174	1
T202	TimeUnits 1174 1177	WPN
T47	TimeEndpointAssessed 2573 2574	1
T203	TimeUnits 2574 2577	DPN
T48	TimeEndpointAssessed 2579 2580	1
T204	TimeUnits 2580 2583	WPN
T49	TimeEndpointAssessed 2589 2590	1
T205	TimeUnits 2590 2593	MPN
T165	TimeEndpointAssessed 2835 2836	1
T206	TimeUnits 2836 2839	DPN
T64	TimeEndpointAssessed 4052 4053	1
T207	TimeUnits 4053 4056	DPN
T82	TimeEndpointAssessed 5900 5901	1
T208	TimeUnits 5901 5904	WPN
T84	TimeEndpointAssessed 5964 5965	1
T209	TimeUnits 5965 5968	MPN
T210	TimeUnits 6185 6188	min
T211	TimeEndpointAssessed 6183 6184;6226 6249	0 after insulin injection
T212	TimeUnits 6222 6225	min
T91	Endpoint 6397 6420	corticosterone analysis
T213	Endpoint 6586 6615	corticosterone level analysis
T107	TimeEndpointAssessed 7562 7563	1
T214	TimeUnits 7563 7566	DPN
T146	TimeEndpointAssessed 7627 7628	1
T215	TimeUnits 7628 7631	DPN
T101	TimeEndpointAssessed 7845 7846	1
T216	TimeUnits 7846 7849	DPN
T217	Dose 7204 7206	50
T218	DoseUnits 7207 7212	mg/kg
T118	EndpointUnitOfMeasure 10283 10337	average intensity of GLUT4 immunofluorescence per cell
T193	EndpointUnitOfMeasure 9345 9409	percentage of insulin-positive area over the total pancreas area
T219	Endpoint 9418 9433	pancreas weight
T191	Endpoint 8447 8460;8937 8958	soleus muscle morphometric analysis
T192	Endpoint 8555 8563;8937 8958	pancreas morphometric analysis
T220	Dose 2670 2672	50
T221	DoseUnits 2673 2678	mg/kg
T222	Dose 4117 4119	40
T223	DoseUnits 4120 4125	mg/kg
T224	Dose 4128 4130	10
T225	DoseUnits 4131 4136	mg/kg
T226	DoseRoute 4152 4176	intraperitoneally (i.p.)
T227	Dose 4686 4687	2
T228	DoseUnits 4688 4714	mg D-glucose/g body weight
T229	Dose 6103 6107	0.75
T230	TestArticle 7213 7237	bromodeoxyuridine (BrdU)
T231	TestArticle 2218 2241	BrDU, bromodeoxyuridine
T232	TestArticle 2679 2683	BrdU
T233	DoseRoute 2684 2701	intraperitoneally
T234	DoseFrequency 2702 2773	twice daily (every 12 hr, early in the morning and late in the evening)
T235	DoseDuration 2778 2779	1
T236	DoseDurationUnits 2780 2783	day
T237	DoseDuration 2848 2849	7
T238	DoseDurationUnits 2861 2865	days
T239	TestArticle 4093 4101	ketamine
T240	TestArticle 4107 4115	xylazine
T241	TestArticle 4677 4684	glucose
T242	DoseRoute 4659 4673	i.p. injection
T243	DoseRoute 6052 6065	injected i.p.
T244	TestArticle 6079 6092	human insulin
T245	TestArticle 6094 6101	Humulin
T246	DoseUnits 6108 6124	U/kg body weight
T247	TestArticle 7505 7509	BrdU
T248	DoseRoute 7291 7295	i.p.
T249	DoseDuration 7529 7530	1
T250	DoseDurationUnits 7531 7534	day
T251	DoseFrequency 7296 7367	twice daily (every 12 hr, early in the morning and late in the evening)
T252	DoseDuration 7372 7373	7
T253	DoseDurationUnits 7385 7389	days
T254	DoseRoute 4430 4445	Intraperitoneal
T255	DoseRoute 4477 4492	intraperitoneal
T256	DoseRoute 6822 6836	i.p. injection
T257	TestArticle 6840 6847	insulin
T258	TestArticle 6849 6856	Humulin
T259	Dose 6858 6862	0.75
T260	DoseUnits 6863 6879	U/kg body weight
T261	TestArticle 7113 7118	noise
T262	TestArticle 9843 9850	insulin
T263	TestArticle 9855 9859	BrdU
T264	DoseDuration 7775 7780	Seven
T265	DoseDurationUnits 7781 7785	days
T266	TestArticle 7804 7808	BrdU
T267	TestArticle 7586 7590	BrdU
T268	DoseDuration 7580 7581	1
T269	DoseDurationUnits 7582 7585	day
